¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immunological rejection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® rejection ÇÑ±Û °ÅºÎ
¼³¸í   
  ¾î¶² °³Ã¼ÀÇ Á¶Á÷À» ´Ù¸¥ °³Ã¼¿¡ À̽ÄÇßÀ» ¶§ ±×°ÍÀ» ¹èÁ¦Çϴ »ýü¹ÝÀÀ. °³Ã¼°£¿¡ À̽ļö¼úÀ» Çϸé Ã³À½ 7~10ÀÏ Á¤µµ´Â Ç÷¾×°ø±Þµµ È¸º¹µÇ°í º°´Ù¸¥ ÀÌ»óÀ» ¹ß°ßÇÏÁö ¸øÇÏÁö¸¸, ±× ÈÄ¿¡ ±«»ç°¡ »ý±ä´Ù. ±× ¶§¹®¿¡ Àå±âÀ̽ĠÈÄ¿¡ °¢Á¾ Áõ»óÀÌ ¹ß»ýÇÏ¿© À̽ļö¼úÀÌ ½ÇÆÐ·Î µ¹¾Æ°¡±â ½±´Ù. »ç¶÷ÀǠü³»¿¡ ÀÌÁ¾ÀÇ Á¶Á÷ÀÌ µé¾î°¡¸é ±×¿¡ ´ëÇØ Ç×ü°¡ ¸¸µé¾îÁø´Ù. À̴ Ç÷¾× ¼ÓÀÇ ¸²ÇÁ±¸°¡ ±× ÀÌÁ¾Á¶Á÷¿¡ Á¢ÃËÇÏ¿© È°¼ºÈ­µÈ »óÅ¿¡¼­ ¸²ÇÁÀý·Î µÇµ¹¾Æ¿Í¼­ °Å±â¼­ Ç×ü¸¦ ¸¸µå´Â °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù. ÀÌ Ç×ü´Â ¼¼Æ÷¼ºÇ×ü¿Í Ã¼¾×¼ºÇ×ü·Î ³ª´©¾îÁö¸ç ÀÌ ¾çÀÚÀÇ °øµ¿ÀÛ¿ë¿¡ ÀÇÇØ °ÅºÎ¹ÝÀÀÀÌ »ý±â´Â °ÍÀ¸·Î º¸ÀδÙ. À̴ °³Ã¼¹æÀ§¹ÝÀÀÀ̶ó°íµµ ÇÒ ¼ö ÀÖÁö¸¸ À̽ÄÁ¶Á÷ÀÇ Ç÷°üÀº ±×°ÍµéÀÇ ÀÛ¿ëÀ¸·Î ³»ÇǼ¼Æ÷°¡ »óÇÏ¿© Ç÷ÀüÀ» Çü¼ºÇϹǷΠÇ÷ÇàÀÌ µÎÀýµÈ´Ù. ±× ¶§¹®¿¡ ±«»ç°¡ »ý±â°í ±«»çÁ¶Á÷Àº Ã¼¿Ü·Î ¹èÃâµÈ´Ù. °ÅºÎ¹ÝÀÀÀº À̽ÄÁ÷ÈÄ¿¡ »ý±â´Â °Í, ¼öÁÖ¿¡¼­ ¼ö°³¿ù ÈÄ¿¡ ºñ±³Àû ±Þ¼ºÀ¸·Î »ý±â´Â °Í, ¼ö³â ÈÄ¿¡ ¼­¼­È÷ »ý±â´Â °ÍÀÌ ÀÖ´Ù. Àå±â À̽Ľÿ¡´Â ÀÌ ¹ÝÀÀÀ» ¾ïÁ¦Çϱâ À§ÇØ ¸é¿ª¾ïÁ¦Á¦³ª ºÎ½Å°ÑÁúÈ£¸£¸óÀ» Åõ¿©ÇÑ´Ù. 
¿µ¹® immunological reaction ÇÑ±Û ¸é¿ª¹ÝÀÀ
¼³¸í   
  »ýüÀÇ ¸ö ¾È¿¡¼­ »ý±ä ¹°ÁúÀ̳ª ¸ö ¹Û¿¡¼­ µé¾î¿Â ¹°ÁúÀÌ »ýü¿Í ´Ù¸¦ ¶§ ÀÚ±â Ã¼³»ÀÇ ÅëÀϼº°ú °³Ã¼ÀÇ »ýÁ¸ À¯Áö ¹× Á¾ÀÇ Á¸¼ÓÀ» À§ÇÏ¿© ±× ¹°ÁúµéÀ» Á¦°ÅÇϴ ÀÏ·ÃÀÇ »ýü ¹ÝÀÀ. ´Ù½Ã ¸»ÇØ B¼¼Æ÷¿¡ ÀÇÇÑ Ç×ü»ý»ê, T¼¼Æ÷¸¦ Áß½ÉÀ¸·Î Çϴ ¼¼Æ÷¼º ¸é¿ª, ¸é¿ª°ü¿ë, ¸é¿ª±â¾ï µîÀÇ »ýü ³» ¹ÝÀÀÀ» ¸»ÇÑ´Ù. Å«Æ÷½Ä¼¼Æ÷´Â Ç׿øÀ» Ã³¸®Çؼ­ Æ¯ÀÌÀûÀΠÇ׿ø°áÁ¤±â¸¦ °®´Â ºÐÀڷΠ¹Ù²ã, Ç׿ø°ú ÁÖ¿äÁ¶Á÷ ÀûÇÕÀ¯ÀüÀÚº¹ÇÕü¸¦ ¼¼Æ÷Ç¥¸é¿¡ Ç¥ÇöÇϸç, T¼¼Æ÷·Î Àü´ÞÇÑ´Ù. ÇÑÆí B¼¼Æ÷´Â Å«Æ÷½Ä¼¼Æ÷ ³»¿¡¼­ Ã³¸®µÈ Ç׿øÀÇ °áÁ¤±â¸¦ ÀνÄÇÏ¿© ´ëÀÀÇϴ ƯÀÌÀûÇ×ü¸¦ »ý»êÇÏ¿© Ç׿øÀ» Ã³¸®ÇÑ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological
    ¸é¿ªÇÐÀû-
  • immunological adjuvant
    ¸é¿ªº¸°­Á¦
  • immunological disease
    ¸é¿ªº´, ¸é¿ªÁúȯ
  • immunological incompetence
    ¸é¿ªºÎÀü
  • immunological recognition
    ¸é¿ªÀνÄ
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • immunological unresponsiveness
    ¸é¿ª¹«¹ÝÀÀ
  • allograft rejection
    µ¿Á¾À̽İźιÝÀÀ
  • cardiac rejection
    ½ÉÀåÀ̽İźιÝÀÀ
  • first-set rejection
    ÀÏÂ÷°ÅºÎ¹ÝÀÀ
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ¹ÝÀÀ
  • homograft rejection
    µ¿Á¾À̽İźιÝÀÀ
  • rejection
    1. °ÅºÎ, °ÅºÎ¹ÝÀÀ 2. °ÅÀý 3. Æó±â
  • rejection reaction
    °ÅºÎ¹ÝÀÀ
  • specimen rejection
    °Ëü°ÅÀý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • rejection
    °ÅºÎ
  • allograft rejection
    µ¿Á¾À̽İźÎ
  • rejection reaction
    °ÅºÎ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • allograft rejection
    µ¿Á¾À̽İźÎ
  • immunological absorbent
    ¸é¿ªÈíÂøÁ¦
  • immunological adjuvant
    ¸é¿ªº¸°­Á¦
  • cardiac rejection
    ½ÉÀåÀ̽İźιÝÀÀ
  • immunological competence
    ¸é¿ªÀû°Ý¼º
  • immunological disease
    ¸é¿ªÁúȯ
  • first-set rejection
    ÀÏÂ÷°ÅºÎ
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ
  • homograft rejection
    µ¿Á¾ÀÌ½ÄÆí°ÅºÎ
  • immunological
    ¸é¿ªÇÐÀû-
  • immunological incompetence
    ¸é¿ªºÎÀü
  • immunological reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
  • immunological recognition
    ¸é¿ªÀÎÁö
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • immunological unresponsiveness
    ¸é¿ª¹«¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological rejection
    ¸é¿ªÇÐÀû°ÅºÎ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ).
  • graft rejection, white
    ¹é»öÈ­ ÀÌ½ÄÆí°ÅºÎ (Ãʱ޼º)
  • homograft rejection
    µ¿Á¾ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ)(¡­°ÅºÎ¹ÝÀÀ).
  • homograft rejection
    µ¿Á¾ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ)(¡­ËÞÜúÚãëë).
  • immunologic rejection
    ¸é¿ªÇÐÀû °ÅºÎ.
  • rejection
    °ÅºÎ (ËÞÜú)
  • rejection phenomenon
    °ÅÀýÇö»ó(ËÞï¾úÞßÚ).
  • rejection phenomenon
    °ÅÀýÇö»ó(ËÞï¾úÞßÚ).
  • rejection reaction
    °ÅÀý(¹ÝÀÀ)(ËÞï¾Úãëë).
  • rejection reaction
    °ÅÀý(¹ÝÀÀ)(ËÞï¾Úãëë).
  • rejection, allograft
    µ¿Á¾À̽Ä(Æí)°ÅºÎ(¹ÝÀÀ)
  • rejection, hypersensitivity to
    °ÅºÎ¿¡ ´ëÇÑ °ú¹Î(-¼º)
  • immunological
    ¸é¿ªÇÐÀû.
  • immunological
    ¸é¿ªÇÐÀû.
  • immunological absorbent
    ¸é¿ªÈíÂøÁ¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological rejection
    ¸é¿ªÇÐÀû°ÅºÎ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • allograft rejection
    µ¿Á¾À̽İźιÝÀÀ
  • allograft rejection
    µ¿Á¾À̽Ä[Æí]°ÅºÎ[¹ÝÀÀ]
  • allograft rejection =homograft r.
    µ¿Á¾À̽Ä(Æí) °ÅºÎ(¹ÝÀÀ).
  • first set rejection
    1Â÷°ÅºÎ(¹ÝÀÀ).
  • first set rejection
    ÀÏÂ÷°ÅºÎ(¹ÝÀÀ).
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ).
  • graft rejection, white
    ¹é»öÈ­ ÀÌ½ÄÆí°ÅºÎ (Ãʱ޼º)
  • homograft rejection
    µ¿Á¾ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ)(¡­ËÞÜúÚãëë).
  • homograft rejection
    µ¿Á¾ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ)(¡­°ÅºÎ¹ÝÀÀ).
  • immunologic rejection
    ¸é¿ªÇÐÀû °ÅºÎ.
  • rejection
    °ÅºÎ (ËÞÜú)
  • rejection phenomenon
    °ÅÀýÇö»ó(ËÞï¾úÞßÚ).
  • rejection phenomenon
    °ÅÀýÇö»ó(ËÞï¾úÞßÚ).
  • rejection reaction
    °ÅÀý(¹ÝÀÀ)(ËÞï¾Úãëë).
  • rejection reaction
    °ÅÀý(¹ÝÀÀ)(ËÞï¾Úãëë).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological rejection
    ¸é¿ª °ÅºÎ(Øóæ¹ËÞÜú)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trnsplant rejection
    À̽ÄÁ¶Á÷ °ÅºÎ(ì¹ãÕðÚòÄËÞÜú)
  • immunological competence
    ¸é¿ª´É(Øóæ¹Òö)
  • immunological enhancement
    ¸é¿ª Áõ°­(Øóæ¹ñòË­)
  • immunological equivalence
    ¸é¿ª ´ç·®(Øóæ¹Ó×Õá)
  • immunological inhibition
    ¸é¿ª ÀúÇØ(Øóæ¹îÁúª)
  • immunological paralysis
    ¸é¿ª ¸¶ºñ(Øóæ¹Ø«Ýö)
  • immunological suppression
    ¸é¿ª ¾ï¾Ð(Øóæ¹åääâ)
  • immunological surveillance theory
    ¸é¿ª °¨½Ã ÀÌ·Ð(Øóæ¹ÊøãÊ×âÖå)
  • immunological tolerance
    ¸é¿ª ³»¼º(Øóæ¹Ò±àõ)
  • immunological unresponsiveness
    ¸é¿ª ¹«´ëÀÀ(Øóæ¹ÙíÓßëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • rejection
    °ÅÀý, °ÅºÎ, ±â°¢
  • transplant rejection
    À̽İźÎ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IT immunological test; immunotherapy; implantation test; individual therapy; information technology; in...
AR absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista...
CMR cardiomodulorespirography; cerebral metabolic rate; chief medical resident; common medical record; c...
CMRR common mode rejection ratio
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
R.I.A. radio-immunological assay
AR Acute Rejection
ACR Acute cellular rejection
ARE Acute rejection episodes
AVR Acute vascular rejection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • immunological
    ¸é¿ªÇÐÀû
    ¸é¿ªÇп¡ °üÇÑ.
  • immunological deficiency state
    ¸é¿ª °áÇÌ »óÅÂ
  • immunological enhancement
    ¸é¿ª Áõ°­ Çö»ó, ¸é¿ª Áõ°­
    ¸é¿ª ¹ÝÀÀÀÇ ¼öÁØÀ» Áõ´ë½ÃŰ´Â ¿©·¯ °¡Áö ƯÀÌÀû ¶Ç´Â ºñƯÀÌÀû »óȲ.
  • immunological incompetence
    ¸é¿ª ºÎÀü
  • immunological paralysis
    ¸é¿ª ¸¶ºñ, ¸é¿ª °ü¿ë
    ´Ù·®ÀÇ Ç׿ø Åõ¿©¿¡ ÀÇÇÏ¿© ¸é¿ªÇÐÀû ¹ÝÀÀÀÌ ¼Ò½ÇµÈ »óÅÂ.
  • immunological resistance
    ¸é¿ª ÀúÇ×
  • immunological tolerance
    ¸é¿ª ³»¼º
    ´Ù¸¥ »óÅ¿¡¼­´Â ü¾×¼º ¶Ç´Â ¼¼Æ÷ ¸Å°³ ¸é¿ªÀ» À¯¹ßÇÒ ¼ö Àִ ƯÁ¤ÀÇ Ç׿ø¿¡ ´ëÇØ¼­, ¸²ÇÁ°è Á¶Á÷ÀÇ Æ¯ÀÌÀû ¹«¹ÝÀÀ¼ºÀÌ ÀϾµµ·Ï µÇ´Â °ÍÀ» Ư¡ÀûÀ¸·Î ÇÏ´Â ¸é¿ª ¹ÝÀÀ.
  • acute rejection vasculitis
    ±Þ¼º °ÅºÎ Ç÷°ü¿°
    ÀÌ½Ä ÈÄ ¸î °³¿ù ³»¿¡ ³ªÅ¸³ª°Å³ª ¸é¿ª¾ïÁ¦¿ä¹ýÀ» Áß´ÜÇßÀ» ¶§ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. ÀÌ·¯ÇÑ È¯ÀÚ´Â ÀÌ½Ä Àå±âÀÇ ±â´ÉÀå¾Ö°¡ ÀÌ½Ä ¼ö¼ú ÈÄ °©Àڱ⠳ªÅ¸³ª¼­ Áö¼Ó¼ºÀ» º¸ÀÌ¸ç °í´ÜÀ§ÀÇ ¸é¿ª¾ïÁ¦¿ä¹ý¿¡ ÀÇÇØ¼­µµ Àß Ä¡À¯µÇÁö ¾Ê´Â´Ù.
  • allogenic rejection
    µ¿Á¾ ÀÌ½Ä °ÅºÎ
    µ¿Á¾ ÀÌ½ÄÆíÀÌ »ýÂøÇÏ´Â ÀÏÀÌ ¾øÀÌ °ÅºÎ´çÇØ¹ö¸®´Â °Í. ÀÌ½ÄÆí°ú °³Ã¼ »çÀÌÀÇ Á¶Á÷ ÀûÇÕ¼º Ç׿øÀÌ ´Ù¸£¸é À̵éÀÇ Ç׿ø¿¡ ´ëÇÑ ¼÷ÁÖÀÇ ¸é¿ª¹ÝÀÀÀÌ ¹æ¾Æ¼è°¡ µÇ¾î ÀÌ½ÄÆíÀÇ ÆÄ±«, Áï ÀÌ½Ä °ÅºÎÀÇ Çö»óÀÌ ¹ß»ýÇÑ´Ù. °ÅºÎÀÇ ÁÖ¿ªÀ» ÇØ³»´Â °ÍÀº ¼¼Æ÷¼º ¸é¿ªÀ̶ó°í ÇÑ´Ù.
  • complete rejection
    ÀüÀûÀÎ °ÅºÎ
  • first set rejection
    ÀÏÂ÷ °ÅºÎ, ÀÏÂ÷ °ÅºÎ ¹ÝÀÀ
    Á¦ 1ȸ°ÀÇ µ¿Á¾ À̽Ŀ¡ ÀϾ´Â °ÅºÎ ¹ÝÀÀÀÇ ¾ç½ÄÀÌ¸ç ºÎÀûÇÕÀÇ Á¤µµ¿¡ µû¶ó 1-3ÁÖ°£ÀÇ Àẹ±â¸¦ °ÅÃÄ ÀÌ½Ä ÆíÀº Å»¶ôÇÑ´Ù. ÀÌ½Ä °ÅºÎ ¹ÝÀÀµµ ºñÀÚ±âÀÇ Ç׿ø¼ºÀ» °¡Áø ¼¼Æ÷¸¦ Á¦°ÅÇϱâ À§ÇÑ ¸é¿ª ¹ÝÀÀÀÌ´Ù.
  • homograft rejection
    µ¿Á¾ ÀÌ½ÄÆí °ÅºÎ ¹ÝÀÀ
    µ¿ÀÏÇÑ Á¾ ³»¿¡¼­ÀÇ À̽Ŀ¡ ´ëÇÑ °ÅºÎ ¹ÝÀÀ.
  • immunologic rejection
    ¸é¿ªÇÐÀû °ÅºÎ
  • proximal tubular rejection
    ÀÎÁ¢ µµ°ü ºÀ¼â
  • rejection
    °ÅÀý, °ÅºÎ, ±â°¢, °ÅºÎ ¹ÝÀÀ
    ÀÌ½Ä Á¶Á÷¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀ. °úÀ× ¿¹¹Î¼º °ÅºÎ·Î ±âÁ¸ÀÇ Ç×ü¿¡ ÀÇÇÏ¿© ÀÌ½ÄÆí¿¡ ´ëÇÑ Áï½Ã ÀÀ´ä ¹ÝÀÀÀÌ ÀϾ ¼¶À¯¼Ò Ä§Âø, Ç÷¼ÒÆÇ ÀÀÁý, È£Áß±¸ ħÀ±ÀÌ ÀϾ¸ç °á±¹Àº À̽ÄÀÇ ½ÇÆÐ·Î ³¡³­´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
models, immunological Theoretical representations that simulate the behaviour or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment.
(12 Dec 1998)
immunological Pertaining to immunology.
(18 Nov 1997)
immunological competence <immunology> The bodys ability to develop an immune response to infection or disease. Immunocompetence is measured to see how well the body can fight off certain disease. Many cancer patients become immunocompromised, where their immune system is not as strong as a healthy person's.
(16 Dec 1997)
immunological deficiency Inabillity to mount a normal immune response. Immunodeficiency can be due to a genetic disease or acquired as in aids due to HIV.
(12 Dec 1998)
immunological disease <immunology> Any illness, such as an allergy, that is caused by the action of antibodies.
(09 Oct 1997)
immunological enhancement In immunology, the potentiating effect of specific antibody in establishing and in delaying rejection of a tumour allograft; aside from antibody, non-specific substances may also act to enhance immune response.
Synonym: immunological enhancement.
(05 Mar 2000)
immunological mechanism The groups of cells (chiefly lymphocytes and cells of the reticuloendothelial system) that function in establishing active acquired immunity (induced sensitivity, allergy).
(05 Mar 2000)
immunological memory <immunology> The systems responsible for the situation where reactions to a second or subsequent exposure to an antigen are more extensive than those seen on first exposure (but See immunological tolerance.
The memory is best explained by clonal expansion and persistence of such clones following the first exposure to antigen.
(18 Nov 1997)
immunological network <immunology> The concept due to Jerne that the entire specific immune system within an animal is made up of a series of interacting molecules and cell surface receptors, based on the idea that every antibody combining site carries its own marker antigens or idiotypes and that these in turn may be recognised by another set of antibody combining sites and so on.
(18 Nov 1997)
immunological paralysis Lack of specific antibody production after exposure to large doses of the antigen; immunological paralysis disappears when the antigen is eliminated.
See: immunologic tolerance.
(05 Mar 2000)
immunological surveillance <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells.
(18 Nov 1997)
immunological tolerance <immunology> Specific unresponsiveness to antigen. Self tolerance is a process occurring normally early in life due to suppression of self reactive lymphocyte clones.
Tolerance to foreign antigens can be induced in adult life by exposure to antigens under conditions in which specific clones are suppressed. Note that tolerance is not the same as immunological unresponsiveness, since the latter may be very non-specific as in immunodeficiency states.
(18 Nov 1997)
accelerated rejection A transplant rejection manifested in less than three days.
(05 Mar 2000)
acute cellular rejection Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage.
See: primary rejection.
Synonym: acute rejection.
(05 Mar 2000)
acute kidney transplant rejection <radiology> Findings on ultrasound: globular enlargment of the kidney, swelling and hypoechogenicity of the medullary pyramids, indistinct cortico-medullary junction, foci in the renal cortex
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • rejection
    °ÅÀý
  • rejection
    ¹èÁ¦;Æó±â;°ÅÀý;°¢ÇÏ;ºÎ°á;±¸Åä;Æó±â¹°;°ÅºÎ(°ÅÀý)¹ÝÀÀ
  • rejection front
    °ÅºÎ Àü¼±(À̽º¶ó¿¤°ú ±³¼·.È­ÆòÀ» °ÅºÎÇÏ´Â ¾Æ¶øÁ¦±¹(Á¶Á÷)ÀÇ Àü¼±)
  • rejection slip
    (ÃâÆÇ»ç°¡ äÅà ¾Ê±â·Î ÇÑ ¿ø°í¿¡ ºÙ¿© º¸³»´Â)°ÅÀý ÂÊÁö;°ÅÀýÇ¥
  • rejection stmptom
    °ÅºÎ ¹ÝÀÀ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á